Commercial Determinants of Health¶

Trace population health and health inequity through the systems, actors, products, practices, and pathways of paid or commercially organized activity pursuing a commercial or revenue-sustaining objective—including profit, growth, cost recovery, market share, or return—and include beneficial as well as harmful effects.

Version: v2 · 2026-09-19 · History
Domain-specific #: 1508
Domain group: Applied Sciences & Engineering
Origin domain: Medicine & Healthcare
Subdomains: Public Health, Social and Structural Determinants of Health → Medicine & Healthcare
Aliases: CDoH

Core Idea¶

Commercial Determinants of Health (CDoH) is the public-health causal framework for tracing how commercial actors and the political-economic environment of commerce shape population health and health inequity. The World Health Organization defines the field broadly around private-sector activities that affect health directly or indirectly, positively or negatively, including commercial activity and the environment in which it occurs. The 2023 Lancet framework condenses the identity as the systems, practices, and pathways through which commercial actors drive health and health inequity.

How would you explain it like I'm…

How Shops Shape Health

The companies that make and sell things, like food, medicine and toys, change how healthy people are. Some of what they do helps, like making safe medicines, and some of what they do can hurt, like making unhealthy snacks cheap and everywhere. Commercial determinants of health means looking carefully at which company actions help or hurt which people.

Business Paths to Health

Commercial determinants of health are the ways businesses affect how healthy people are. Companies decide what to sell, how much it costs, how to advertise it, how they treat their workers, and what rules they ask governments to make. All of these choices change what people can buy, what they want, and what they are exposed to, which can make whole groups healthier or sicker. The effects can be good, like affordable medicines or safer products, or bad, like pollution or ads for harmful products. Health researchers study which company, which action, and which people are involved, rather than just blaming all businesses.

Commercial Pathways to Population Health

Commercial determinants of health (CDoH) is a public-health framework for tracing how commercial actors and the wider economic and political system around commerce shape population health and health inequity. Instead of stopping at an individual's choice, like what someone ate, it looks 'upstream' at product ranges, prices, marketing, supply chains, working conditions, research funding, lobbying and legal strategy. These change what is available and affordable, what people want, which evidence gets noticed, and which laws pass. Importantly, the framework is 'signed': commercial activity can harm health (tobacco promotion, pollution) or help it (essential medicines, safer products, paid leave). The analysis asks which actor, which practice, which pathway and which population — rather than assuming all business is bad.

Commercial Determinants of Health (CDoH) is a public-health causal framework for tracing how commercial actors, and the political-economic environment in which commerce operates, shape population health and health inequity. The WHO frames it broadly around private-sector activities that affect health directly or indirectly, positively or negatively, and the 2023 Lancet framework summarizes it as the systems, practices and pathways through which commercial actors drive health and inequity. The analysis moves upstream from individual behavior or diagnosis to product portfolios, pricing, marketing, distribution, employment, supply chains, research funding, lobbying, legal strategy, financial practice and the rules that allocate commercial power. These practices alter availability, affordability, cultivated preferences, the salience of evidence, workplace and environmental conditions, and policy outcomes, forming a causal chain from commercial organization to exposure and protection to population outcomes. The 2016 formulation emphasized strategies promoting health-damaging products; later work broadened to diverse actors, effects of either sign, and enabling systems. A full account specifies the commercial activity and actor attributes, the practices, a documented pathway, the population-health consequence with direction, magnitude, distribution and uncertainty, and feedback through markets, governance and accumulated power. The framework is signed, not accusatory by definition, and warns against treating all commercial entities as one harmful class.

Scope of Application¶

CDoH analysis applies across tobacco, alcohol, ultra-processed foods, sugar-sweetened beverages, gambling, firearms, automobiles, pharmaceuticals, health care, digital platforms, fossil fuels, mining, agriculture, finance, housing, transport, and many other sectors. It also applies to cross-sector practices: targeted marketing, price discrimination, research sponsorship, lobbying, litigation, tax strategy, labor contracting, procurement, supply-chain control, mergers, and political donations.

The unit of analysis can be one product-practice pathway, one firm or industry, a portfolio, a population, a country, or a global commercial system.

Clarity¶

The abstraction separates four commonly conflated layers:

Actor: who is acting, with what portfolio, scale, ownership, resources, and market position?
Practice: what did the actor do or omit—design, price, market, hire, pollute, fund, lobby, litigate, distribute, disclose, or reform?
Pathway: what changed between that practice and health—exposure, access, evidence, preference, policy, work, income, environment, or service conditions?
Outcome and distribution: which health measure moved, for which population, in which direction, compared with what alternative?

Manages Complexity¶

Population health rarely follows one commercial cause. A firm's products, marketing, supply chain, labor model, financing, and political activity can act jointly, while multiple firms share distributors, trade associations, media channels, and regulatory environments. CDoH manages this complexity with a causal map whose nodes remain separately observable: actor attributes, practices, enabling systems, intermediate determinants, outcomes, and equity strata.

Abstract Reasoning¶

A useful CDoH representation is a signed multilevel causal graph:

\[ A,S \rightarrow P \rightarrow D \rightarrow H,Q, \]

where \(A\) denotes actor attributes, \(S\) the enabling commercial system, \(P\) a practice, \(D\) the intermediate determinant or exposure, \(H\) the population-health outcome, and \(Q\) its equity distribution. Feedback arrows return from revenue, market share, legitimacy, and accumulated power to \(A\), \(S\), and future \(P\).

Knowledge Transfer¶

The actor–practice–pathway–outcome structure transfers across public-health topics. A tobacco analyst, an occupational-health researcher, and a digital-platform researcher can use the same questions: what is sold, how revenue is made, which practice changes exposure or governance, who is affected, and how power feeds back. Methods for documenting political activity or scientific influence can likewise transfer across industries while remaining sensitive to sector differences.

Relationships to Other Abstractions¶

Current abstraction Commercial Determinants of Health Domain-specific

Parents (2) — outgoing typed relations

Commercial Determinants of Health is a kind of Systems Thinking Prime

CDoH instantiates Systems Thinking because it analyzes population health through relationships and feedback among commercial actors, products, practices, governance, environments, and populations rather than isolating one downstream.
Commercial Determinants of Health presupposes Causality Prime

CDoH instantiates Systems Thinking because it analyzes population health through relationships and feedback among commercial actors, products, practices, governance, environments, and populations rather than isolating one downstream.

Hierarchy paths (4) — routes to 4 parentless roots

Commercial Determinants of Health → is a kind of Systems Thinking → presupposes Emergence → is a decomposition of Micro Macro Linkage

Show alternative paths (3)

Neighborhood in Abstraction Space¶

Commercial Determinants of Health sits in a sparse region of the domain-specific corpus (71^st percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (2769 abstractions)

Nearest neighbors

Corporate accountability for human rights violations — 0.86
Founder-Market Fit — 0.84
Estate planning — 0.83
Instrumental and Value Rationality — 0.83
Coopetition — 0.83

Computed from structural-signature embeddings · 2026-10-25